Patent ID: 9271904
Filing Date: 2016-03-01
CPC Classification: A23G,A23L,A61K,A61Q

Claim Text:
1. An oral delivery system comprising: at least one active component; wherein the at least one active component is an anticalculus agent is selected from the group consisting of pyrophosphates, triphosphates, polyphosphates, polyphosphonates and combinations thereof; and a polymer matrix at least partially encapsulating said at least one active component, said polymer matrix having a tensile strength of at least 6,500 psi and comprising at least one polymer having a water absorption of about 0.1% to about 15% by weight as measurable by ASTM D570-98 and hydrogenated oil; wherein the polymer is selected from the group consisting of polyvinyl acetate, polyvinyl acetatephthalate, polymethylmethacrylate, polyethylene terephthalate and combinations thereof.